FDA approves Rapamune to treat LAM, a very rare lung disease

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm448523.htm

 

May 28, 2015

The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age. This is the first drug approved to treat the disease.

(以下略)

USFDA_20150528.jpg   

 


 

 

第一個美國FDA核准用以治療此病的藥物

生產Rapamune的輝瑞官網也有好長一篇:

 

Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM), A Rare Progressive Lung Disease

http://www.pfizer.com/news/press-release/press-release-detail/pfizer_s_rapamune_sirolimus_becomes_first_fda_approved_treatment_for_lymphangioleiomyomatosis_lam_a_rare_progressive_lung_disease

 

 


 

 

 

自費好貴啊~什麼時候輪到我們~什麼時候輪到我們~什麼時候輪到我們~

 

 

創作者介紹
創作者 psadirak 的頭像
psadirak

psadirak

psadirak 發表在 痞客邦 留言(0) 人氣()